ScreenerHero

ICU SeaStar Medical Holding Corporation

NAS · US · Healthcare · Biotechnology · seastarmedical.com
3.720USD+16.61%Mkt Cap: 19.57M $P/E: —

SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap19.57M USD
Enterprise Value7.23M USD
Revenue (TTM)1.71M USD
Gross Profit1.18M USD
Net Income (TTM)-12.15M USD
Revenue/Share0.48 USD
Last Price3.720 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees18
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.24
PEG—
EV/EBITDA—
EV/Revenue4.22
P/S8.21
P/B3.16
EPS (TTM)-2.97
EPS (Forward)-2.57
52W Range
2.07031% of range7.350
52W High7.350 USD
52W Low2.070 USD
Profitability
Gross Margin95.71%
Oper. Margin-616.42%
EBITDA Margin0.00%
Profit Margin-984.60%
ROE-116.65%
ROA-85.82%
Growth
Revenue Growth82.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.60M USD
CapEx (TTM)—
FCF Margin-533.63%
FCF Yield-46.71%
Net Debt-6.83M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.05
Current Ratio1.89
Quick Ratio1.65
Book Value/Sh1.01 USD
Cash/Share1.58 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJan 5, 2026
Analyst Consensus
Rating—
Target (Mean)10.00 USD
Upside (mean)+168.8%
Target Range8.000 USD – 12.00 USD
8.000+168.8% to mean12.00
# Analysts2
Ownership
Shares Out.4.41M
Float4.36M
Insiders11.62%
Institutions7.62%
Short Interest
Short Ratio2.6d
Short % Float2.78%
Short % Out.2.76%
Shares Short121.69K
Short (prev mo.)121.69K
Technical
SMA 503.306 (+12.5%)
SMA 2003.282 (+13.3%)
Beta-1.07
S&P 52W Chg16.45%
Avg Vol (30d)130.44K
Avg Vol (10d)144.75K
Technical Indicators
RSI (14)53.1
MACD0.1162
MACD Signal0.0943
MACD Hist.+0.0219
BB Upper4.258 USD
BB Middle3.457 USD
BB Lower2.656 USD
BB Width46.37%
ATR (14)0.4177 USD
Vol Ratio (20d)12.96x